Loading...
XSWX
MED
Market cap1.23bUSD
Oct 09, Last price  
82.40CHF
1D
0.98%
1Q
-9.65%
IPO
31.84%
Name

Medartis Holding AG

Chart & performance

D1W1MN
XSWX:MED chart
P/E
122.84
P/S
3.81
EPS
0.67
Div yield, %
—
Shrs. gr., 5y
1.13%
Rev. gr., 5y
16.10%
Revenues
269m
+19.76%
82,302,85092,502,392105,040,292121,324,702130,143,937127,645,985159,880,236182,824,418212,006,000224,831,000269,257,000
Net income
8m
+136.65%
7,270,9493,314,395866,5214,201,9072,146,521-943,5656,837,867-5,782,888619,0003,528,0008,349,000
CFO
35m
+8.56%
11,877,11711,908,64011,012,9946,449,4648,114,01712,610,80620,952,678-3,927,46019,980,00032,072,00034,817,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Medartis Holding AG is a global medical technology firm that develops, manufactures, and distributes implantable solutions. These advanced medical devices are utilized worldwide for the surgical stabilization of bone fractures in both the upper and lower extremities, in addition to addressing complex cranio-maxillofacial surgical needs. The company's portfolio features osteosynthesis instruments, marketed under the APTUS and MODUS brands, specifically designed for various body regions including the hand, wrist, elbow, shoulder, foot, and ankle, as well as for facial and skull procedures involving the mandible, midface, orthognathic structures, and cranium. Medartis serves a diverse clientele comprising surgeons, hospitals, medical centers, and group purchasing organizations. The company, founded in 1997, is headquartered in Basel, Switzerland.

Related entities

Subsidiaries (2)
Medartis AG
MEDARTIS INTERNATIONAL FINANCE SAS

Key people

Non-Executive Vice Chairman of the Board · since 2021
Caroline Knoeri
Chief Human Resources Officer, Member of the Executive Management Board · since 2025
Marc Ammann
Executive Vice President - R&D and Innovation, Member of the Executive Management Board · since 2025
Mario Della Casa
Chief Operating Officer, Member of the Executive Management Board · since 2022
Dirk Kirsten
Chief Financial Officer, Member of the Executive Management Board · since 2021
Manuel Schaer
Chief Technology Officer, Member of the Executive Management Board · since 2020
Chief Executive Officer, Member of the Executive Management Board · since 2024
Mareike Loch
President - EMEA, Member of the Executive Management Board · since 2024
Inge Maes
Chief Human Resource Officer, Member of the Executive Management Board · since 2024
David Thoni
US President, Member of the Executive Management Board · since 2025
Non-Executive Independent Chairman of the Board · since 2022
Jennifer Dean
Non-Executive Independent Member of the Board · since 2024
Willi Miesch
Non-Executive Independent Member of the Board · since 2023
Ciro Roemer
Non-Executive Independent Member of the Board · since 2022
Nadia Schmidt
Non-Executive Independent Member of the Board · since 2022
Martha Shadan
Non-Executive Independent Member of the Board · since 2024
Non-Executive Independent Member of the Board · since 2022
IPO date
Mar 23, 2018
Employees
858
Domiciled in
CH
Incorporated in
CH
Headquarters & legal address
Hochbergerstr. 60E
Basel, BS 4057
CH

Valuation

Title
CHF in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT